Loading clinical trials...
Loading clinical trials...
Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease that occurs in adults. It is characterized by a progressive degeneration of the first and second motor neurons leading to muscle fai...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire Dijon
NCT06280079 · Amyotrophic Lateral Sclerosis
NCT06051123 · ALSFTD, ALS (Amyotrophic Lateral Sclerosis), and more
NCT05204017 · Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis, and more
NCT07322003 · Amyotrophic Lateral Sclerosis
NCT07414212 · Amyotrophic Lateral Sclerosis
Chu Dijon Bourogne
Dijon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions